Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Moderna
MRNA
|
+$923M |
| 2 |
Amazon
AMZN
|
+$813M |
| 3 |
Apple
AAPL
|
+$809M |
| 4 |
Microsoft
MSFT
|
+$775M |
| 5 |
Tesla
TSLA
|
+$664M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
| 5 |
Oracle
ORCL
|
+$124M |
Sector Composition
| 1 | Technology | 24.55% |
| 2 | Financials | 13.94% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNT
3051
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.93M | ﹤0.01% |
+511,618
| New | +$3.93M |
|
3052
NWPX Infrastructure, Inc. Common Stock
NWPX
$515M
| $3.92M | ﹤0.01% |
165,570
-1,387
| -0.8% | -$32.9K |
|
3053
Definitive Healthcare
DH
$430M
| $3.9M | ﹤0.01% |
+91,169
| New | +$3.9M |
|
3054
Perella Weinberg Partners
PWP
$1.45B
| $3.89M | ﹤0.01% |
293,411
+273,218
| +1,353% | +$3.62M |
|
3055
Cardiff Oncology
CRDF
$138M
| $3.88M | ﹤0.01% |
582,157
+67,176
| +13% | +$447K |
|
3056
SkyWater Technology
SKYT
$491M
| $3.88M | ﹤0.01% |
142,507
+5,749
| +4% | +$156K |
|
3057
eGain
EGAN
$219M
| $3.88M | ﹤0.01% |
379,961
+4,700
| +1% | +$47.9K |
|
|
TCRR
3058
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $3.87M | ﹤0.01% |
454,333
-37,503
| -8% | -$319K |
|
3059
Nordic American Tanker
NAT
$692M
| $3.86M | ﹤0.01% |
1,509,744
+64,076
| +4% | +$164K |
|
3060
Prudential
PUK
$35.8B
| $3.86M | ﹤0.01% |
98,525
-3,056
| -3% | -$120K |
|
3061
Olympic Steel
ZEUS
$378M
| $3.86M | ﹤0.01% |
158,464
-4,965
| -3% | -$121K |
|
|
VIRX
3062
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.86M | ﹤0.01% |
481,301
+32,065
| +7% | +$257K |
|
|
AWH
3063
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $3.85M | ﹤0.01% |
79,012
+1,421
| +2% | +$69.3K |
|
3064
Red River Bancshares
RRBI
$435M
| $3.85M | ﹤0.01% |
77,159
+388
| +0.5% | +$19.3K |
|
3065
Dianthus Therapeutics
DNTH
$1.22B
| $3.85M | ﹤0.01% |
33,017
+1,568
| +5% | +$183K |
|
|
SYRS
3066
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.83M | ﹤0.01% |
85,765
-10,880
| -11% | -$486K |
|
|
SOLY
3067
DELISTED
Soliton, Inc.
SOLY
| $3.8M | ﹤0.01% |
186,759
+18,504
| +11% | +$377K |
|
3068
Foghorn Therapeutics
FHTX
$298M
| $3.8M | ﹤0.01% |
272,707
+34,963
| +15% | +$487K |
|
3069
Design Therapeutics
DSGN
$339M
| $3.79M | ﹤0.01% |
258,032
+5,272
| +2% | +$77.4K |
|
3070
Korro Bio
KRRO
$323M
| $3.78M | ﹤0.01% |
10,720
-209
| -2% | -$73.8K |
|
3071
Rocket Lab Corporation Common Stock
RKLB
$23.4B
| $3.78M | ﹤0.01% |
234,615
+213,014
| +986% | +$3.44M |
|
3072
INNOVATE Corp
VATE
$66.8M
| $3.78M | ﹤0.01% |
92,093
+2,006
| +2% | +$82.2K |
|
|
EBET
3073
DELISTED
EBET, INC. Common Stock
EBET
| $3.77M | ﹤0.01% |
3,744
+2,463
| +192% | +$2.48M |
|
3074
Ceco Environmental
CECO
$1.68B
| $3.76M | ﹤0.01% |
534,651
+7,546
| +1% | +$53.1K |
|
3075
InfuSystem Holdings
INFU
$207M
| $3.76M | ﹤0.01% |
288,298
+4,833
| +2% | +$63K |
|